N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Stock data | 2024 | Change |
---|---|---|
Price | $0.007920060192457463 | N/A |
Market Cap | $2.13M | N/A |
Shares Outstanding | 268.78M | N/A |
Employees | 5.00 | N/A |